IE
OCDX

Israel Englander’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Israel Englander’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-518,275
Closed -$9.67M – 7856
2022
Q1 		$9.67M Buy
518,275
+507,967
+4,928% +$9.14M 0.01% 2205
2021
Q4 		$220K Sell
10,308
-552,181
-98% -$10.9M ﹤0.01% 5833
2021
Q3 		$10.4M Sell
562,489
-275,544
-33% -$5.55M 0.01% 2005
2021
Q2 		$17.9M Buy
+838,033
New +$17M 0.01% 1298

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Israel Englander's OCDX Position: Q2 2022 in Review

Israel Englander sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 518,275 shares — an estimated $9.67M sold.

Israel Englander first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $17.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Israel Englander reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 518,275 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $9.67M.
  • Israel Englander first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • Israel Englander's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $17.9M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.